Cutting-edge Biology: Net profit of 227 million yuan in the first quarter.

Frontier Bio announcement: In the first quarter of 2026, the operating income was 297 million yuan, compared to 28.3282 million yuan in the same period last year. Net profit was 227 million yuan, compared to a loss of 441.215 million yuan in the same period last year.